Fulcrum Therapeutics, Inc. (FULC)

NASDAQ: FULC · Real-Time Price · USD

7.44

-0.28 (-3.63%)

At close: Apr 28, 2026, 4:00 PM EDT

7.51

+0.07 (0.94%)

Pre-market: Apr 29, 2026, 7:38 AM EDT

Fulcrum Therapeutics Market Cap

Fulcrum Therapeutics has a market cap or net worth of $495.75 million as of April 29, 2026. Its market cap has increased by 241.42% in one year.

Market Cap

495.75M

Enterprise Value

168.30M

1-Year Change

241.42%

Ranking

#3079

Market Cap Chart

Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $495.75M, an increase of 64.35%. That is a compound annual growth rate of 7.60%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	495.09M	-33.65%
Dec 31, 2025	746.12M	194.32%
Dec 31, 2024	253.51M	-39.25%
Dec 29, 2023	417.30M	10.13%
Dec 30, 2022	378.93M	-47.15%
Dec 31, 2021	716.95M	124.42%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Upstream Bio	517.53M
Tectonic Therapeutic	510.72M
MiMedx Group	505.13M
Zura Bio	502.87M
Lyell Immunopharma	500.98M
Valneva SE	491.15M
XOMA Royalty	486.88M
Adlai Nortye	486.80M

Market Cap Rankings